Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, today announced the launch of the GIBCO(R) AlgiMatrix(TM) 3D culture system, an animal-origin free bioscaffold that more closely mimics the conditions of a cell in the human body. AlgiMatrix(TM) provides superior cell loading, nutrient delivery and potential for cell-to-cell interaction."AlgiMatrix(TM) meets the growing demand in cell culture to replace two-dimensional culture dishes with 3D scaffolds," said Nicolas Barthelemy, Invitrogen's Senior Vice President, Cell Culture Systems. "This scaffolding better mirrors the environment experienced by normal cells in the body, and enables inter-cellular interactions with more realistic biology and functional relevance. AlgiMatrix(TM) is suitable for many cell-based screening, drug discovery, and human cell therapy procedures."
Unlike animal-derived 3D matrices, AlgiMatrix(TM), a macroporous alginate sponge structure, delivers more consistent results to support the growth of diverse cell types. It is also available at room temperature.
AlgiMatrix(TM) is the latest offering from Invitrogen as part of a growing product portfolio in the cell culture system business. Recently, the company acquired Cascade Biologics, a Portland, Oregon-based company with expertise in the development and manufacture of primary cells and specialized media and supplements. The company's objective is to provide next-generation cell culture systems that serve specific disease-focused research sectors with tailored solutions.
"Cell biology involves so much more than keeping cells alive in the lab. It requires cell characterization and monitoring throughout the experiment, and sensitive assay readouts for meaningful scientific results. By combining our cell culture capabilities with labeling and detection technologies from our Molecular Probes subsidiary, we believe we can offer our customers complete solutions for conducting better, more complete research into the biology of cells," Barthelemy said.
About Invitrogen
Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company is celebrating 20 years of accelerating scientific discovery. Invitrogen globally employs approximately 4,300 scientists and other professionals and had revenues of more than $1.15 billion in 2006. For more information, visit www.invitrogen.com
No comments:
Post a Comment